- Home
- AP vs MDCX Comparison
AP vs MDCX Comparison
Compare AP & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AP | MDCX |
|---|---|---|
| Founded | 1929 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.5M | 45.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AP | MDCX |
|---|---|---|
| Price | $2.74 | $1.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | 193.2K | ★ 259.6K |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $426,314,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.20 | N/A |
| 52 Week Low | $1.75 | $1.79 |
| 52 Week High | $3.99 | $8.94 |
Technical Indicators
Market Signals| Indicator | AP | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 62.70 | 39.84 |
| Support Level | $2.46 | $1.90 |
| Resistance Level | $2.99 | $2.28 |
| Average True Range (ATR) | 0.30 | 0.17 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 77.83 | 1.11 |
Price Performance
Historical ComparisonAbout AP Ampco-Pittsburgh Corporation
Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.